These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6133408)

  • 1. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.
    Lundberg JM; Tatemoto K
    Acta Physiol Scand; 1982 Dec; 116(4):393-402. PubMed ID: 6133408
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the contractile effect of neuropeptide Y in feline cerebral arteries.
    Edvinsson L
    Acta Physiol Scand; 1985 Sep; 125(1):33-41. PubMed ID: 2864784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y may mediate effects of sympathetic nerve stimulations on colonic motility and blood flow in the cat.
    Hellström PM; Olerup O; Tatemoto K
    Acta Physiol Scand; 1985 Aug; 124(4):613-24. PubMed ID: 2864782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y (NPY) and sympathetic control of blood flow in oral mucosa and dental pulp in the cat.
    Edwall B; Gazelius B; Fazekas A; Theodorsson-Norheim E; Lundberg JM
    Acta Physiol Scand; 1985 Oct; 125(2):253-64. PubMed ID: 2866663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular effects of the peptides PYY and PHI: comparison with APP and VIP.
    Lundberg JM; Tatemoto K
    Eur J Pharmacol; 1982 Sep; 83(1-2):143-6. PubMed ID: 6897040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
    Pernow J; Kahan T; Hjemdahl P; Lundberg JM
    Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-adrenergic, non-cholinergic vascular control with reference to neuropeptide Y, vasoactive intestinal polypeptide and nitric oxide.
    Modin A
    Acta Physiol Scand Suppl; 1994; 622():1-74. PubMed ID: 7524267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J; Lundberg JM
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoceptor subtypes involved in neurally evoked sympathetic vasoconstriction in the anterior choroid of cats.
    Koss MC; Gherezghiher T
    Exp Eye Res; 1993 Oct; 57(4):441-7. PubMed ID: 8282030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?
    Wahlestedt C; Håkanson R
    Med Biol; 1986; 64(2-3):85-8. PubMed ID: 3018392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sympathetic stimulation on salivary secretion in submandibular gland in the rabbit stimulated by pilocarpine.
    Moreno M; Martínez de Victoria E; López MA
    Rev Esp Fisiol; 1984 Mar; 40(1):15-8. PubMed ID: 6147000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromodulation of the cardiac vagus: comparison of neuropeptide Y and related peptides.
    Kilborn MJ; Potter EK; McCloskey DI
    Regul Pept; 1985 Oct; 12(2):155-61. PubMed ID: 2866566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action.
    Wahlestedt C; Edvinsson L; Ekblad E; Håkanson R
    J Pharmacol Exp Ther; 1985 Sep; 234(3):735-41. PubMed ID: 3928874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic inhibitory effects of the peptides NPY, PYY and PP on nicotinic EPSPs in guinea-pig gastric myenteric neurones.
    Schemann M; Tamura K
    J Physiol; 1992; 451():79-89. PubMed ID: 1403832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
    Malmström RE; Lundberg JM
    Acta Physiol Scand; 1997 Nov; 161(3):327-38. PubMed ID: 9401585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sympathetic effects on fibrillary activity of denervated striated muscles.
    Luco CF; Luco JV
    J Neurophysiol; 1971 Nov; 34(6):1066-71. PubMed ID: 4398927
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of pancreatic polypeptides and neuropeptide Y on the rat vas deferens.
    Ohhashi T; Jacobowitz DM
    Peptides; 1983; 4(3):381-6. PubMed ID: 6688871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
    Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
    Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats.
    Zukowska-Grojec Z; Haass M; Bayorh MA
    Regul Pept; 1986 Sep; 15(2):99-110. PubMed ID: 3786837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.